Molecular mechanisms promoting neuronal death in amyotrophic lateral sclerosis (ALS) were investigated using transgenic mice that overexpressed the G86R mutated form of the Cu/Zn superoxide dismutase (SOD1) gene. We observed: (i) alteration of the Bcl-x/Bax ratio and (ii) activation of the transcription factor p53, as deduced from its location within neuron nuclei. We further demonstrated that ectopic expression of the G86R mutant SOD1 in PC12 cells enhanced both p53 expression and phosphorylation, leading to transcriptional stimulation of p53-responsive genes. These findings provide evidence that the p53 signaling pathway is activated in SOD1-linked familial ALS and may play a causative role in spinal cord neuron apoptosis by modulating the Bcl-x/Bax ratio.
INTRODUCTION
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder primarily affecting the motor system (Mulder et al., 1986) . Although the majority of ALS cases occur sporadically, some are familial (FALS), exhibiting an autosomal dominant pattern of inheritance (Siddique, 1991) . Not all genes involved in FALS have been identified, but a subset of cases results from mutations in the Cu/Zn superoxide dismutase (SOD1) gene (Rosen et al., 1993) . The identification of these mutations has allowed the production of transgenic mice with mutated SOD1 genes. These animals develop a precipitous, age-related loss of motor neurons that strongly resembles human ALS (Gurney et al., 1994; Ripps et al., 1995; Wong et al., 1995) , thus representing valuable models to investigate the molecular mechanisms underlying motor neuron degeneration in this disease.
Apoptotic nerve cell death now appears likely to underlie a number of neurodegenerative diseases such as Alzheimer's and Parkinson's diseases and ALS. When autopsy specimens from ALS patients were studied for expression of the antiapoptotic bcl-2 gene, and its apoptosis-promoting counterpart bax, decreased expression of bcl-2 and increased expression of bax were apparent (Mu et al., 1996) . However, because these samples were taken from symptomatic individuals, the findings cannot ascertain whether altered gene expression was a secondary marker of cell death or the cause of it. In transgenic mice with altered SOD1 gene, bcl-2 overexpression has been shown to delay motor neuron loss (Kostic et al., 1997) . Again, these findings implicate apoptosis in the process of ALS degeneration, but they do not prove that it is causative.
In order to address this question further, we studied the expression of apoptosis-regulating genes in trans-
